Valeant Pharmaceuticals International, Inc
Valeant Pharmaceuticals International, Inc., is a multinational specialty pharmaceutical company headquartered in Laval, Quebec. The company was founded in 1959 by Ludwig Knoll and Gustav Marton as a small research-based drug manufacturer. In 1989, the company restructured and changed its name to ICN Pharmaceuticals; then in 2010 after multiple mergers, acquisitions and divested operations over the years it rebranded again as Valeant Pharmaceuticals International, Inc. Today they are one of the world’s leading specialty pharmaceutical companies with a focus on dermatology and eye health products development, marketing and distribution worldwide. They currently have an expansive portfolio consisting of branded medications for various therapeutic areas such as neurology neurological disorders, gastrointestinal diseases and infectious diseases along with generic drugs.
Headquarters
400 SOMERSET CORPORATE BLVD., BRIDGEWATER, NJ 08807